Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Volumetric Symmetry after Unilateral Autologous Breast Reconstruction: A Reasonable Goal.

Glener AD, Suresh V, Shammas RL, Broadwater G, Sergesketter A, Taskindoust M, Guo X, Hollenbeck ST.

Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2362. doi: 10.1097/GOX.0000000000002362. eCollection 2019 Sep.

2.

"Occurrence of Symptomatic Hypotension in Patients Undergoing Breast Free Flaps; Is ERAS to blame?"

Anolik RA, Sharif-Askary B, Hompe E, Hopkins TJ, Broadwater G, Hollenbeck ST.

Plast Reconstr Surg. 2019 Dec 17. doi: 10.1097/PRS.0000000000006537. [Epub ahead of print]

PMID:
31860508
3.

Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.

Mremi A, Broadwater G, Jackson K, Amsi P, Mbulwa C, Hyslop T, Ong C, Hall A.

PLoS One. 2019 Nov 8;14(11):e0224760. doi: 10.1371/journal.pone.0224760. eCollection 2019.

4.

The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.

Cocce KJ, Jasper JS, Desautels TK, Everett L, Wardell S, Westerling T, Baldi R, Wright TM, Tavares K, Yllanes A, Bae Y, Blitzer JT, Logsdon C, Rakiec DP, Ruddy DA, Jiang T, Broadwater G, Hyslop T, Hall A, Laine M, Phung L, Greene GL, Martin LA, Pancholi S, Dowsett M, Detre S, Marks JR, Crawford GE, Brown M, Norris JD, Chang CY, McDonnell DP.

Cell Rep. 2019 Oct 22;29(4):889-903.e10. doi: 10.1016/j.celrep.2019.09.032.

5.

Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors.

Zhu L, Narloch JL, Onkar S, Joy M, Broadwater G, Luedke C, Hall A, Kim R, Pogue-Geile K, Sammons S, Nayyar N, Chukwueke U, Brastianos PK, Anders CK, Soloff AC, Vignali DAA, Tseng GC, Emens LA, Lucas PC, Blackwell KL, Oesterreich S, Lee AV.

J Immunother Cancer. 2019 Oct 18;7(1):265. doi: 10.1186/s40425-019-0755-1.

6.

Subjective and objective evaluation of breast temperature following post-mastectomy reconstruction.

Sharif-Askary B, Vernon R, Broadwater G, Lane WO, Pomann GM, Hollenbeck ST.

Breast J. 2019 Sep 6. doi: 10.1111/tbj.13599. [Epub ahead of print] No abstract available.

PMID:
31493299
7.

Gender variation in Medicare utilization and payments in gynecologic oncology.

Lim SL, Puechl AM, Broadwater G, Ehrisman JA, Lorenzo A, Foote J, Davidson BA, Chino J, Havrilesky LJ.

Gynecol Oncol. 2019 Sep;154(3):602-607. doi: 10.1016/j.ygyno.2019.06.007. Epub 2019 Jul 12.

PMID:
31303256
8.

Assessing the Relationship between Anxiety and Revision Surgery following Autologous Breast Reconstruction.

Orr JP, Sergesketter AR, Shammas RL, Thomas AB, Cason RW, Zhao R, Broadwater G, Hollenbeck ST.

Plast Reconstr Surg. 2019 Jul;144(1):24-33. doi: 10.1097/PRS.0000000000005696.

PMID:
31246794
9.

Reduction in opioid use and postoperative pain scores after elective laparotomy with implementation of enhanced recovery after surgery protocol on a gynecologic oncology service.

Schwartz AR, Lim S, Broadwater G, Cobb L, Valea F, Marosky Thacker J, Habib A, Havrilesky L.

Int J Gynecol Cancer. 2019 Jun;29(5):935-943. doi: 10.1136/ijgc-2018-000131. Epub 2019 May 2.

PMID:
31155518
10.

The Effect of Enhanced Recovery after Surgery Pathway Implementation on Abdominal-Based Microvascular Breast Reconstruction.

Sharif-Askary B, Hompe E, Broadwater G, Anolik R, Hollenbeck ST.

J Surg Res. 2019 Oct;242:276-285. doi: 10.1016/j.jss.2019.04.062. Epub 2019 May 21.

PMID:
31125841
11.

Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.

Veade AE, Foote J, Ehrisman J, Broadwater G, Davidson BA, Lee PS, Secord AA, Berchuck A, Havrilesky LJ.

World J Surg Oncol. 2019 May 10;17(1):80. doi: 10.1186/s12957-019-1620-x.

12.

Detecting geriatric needs in older patients with breast cancer through use of a brief geriatric screening tool.

Kikuchi R, Broadwater G, Shelby R, Robertson J, Zullig LL, Maloney B, Meyer C, Mungal D, Marcom PK, Kanesvaran R, White H, Kimmick G.

J Geriatr Oncol. 2019 Nov;10(6):968-972. doi: 10.1016/j.jgo.2019.04.010. Epub 2019 Apr 17.

PMID:
31005647
13.

Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.

Secord AA, McCollum M, Davidson BA, Broadwater G, Squatrito R, Havrilesky LJ, Gabel AC, Starr MD, Brady JC, Nixon AB, Duska LR.

Gynecol Oncol. 2019 Jun;153(3):555-561. doi: 10.1016/j.ygyno.2019.03.246. Epub 2019 Mar 28.

PMID:
30929823
14.

A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery.

Watson CH, Lopez-Acevedo M, Broadwater G, Kim AH, Ehrisman J, Davidson BA, Lee PS, Valea F, Berchuck A, Havrilesky LJ.

Gynecol Oncol. 2019 May;153(2):399-404. doi: 10.1016/j.ygyno.2019.02.021. Epub 2019 Mar 15.

PMID:
30879878
15.

Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.

Kelsey CR, Broadwater G, James O, Chino J, Diehl L, Beaven AW, Chang C, Koontz BF, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):96-101. doi: 10.1016/j.ijrobp.2019.02.055. Epub 2019 Mar 8.

PMID:
30858144
16.

The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.

Puechl AM, Edwards J, Suri A, Nakayama J, Bean S, Gehrig P, Saks E, Duska L, Broadwater G, Ehrisman J, Horowitz N, Secord AA.

Gynecol Oncol. 2019 Apr;153(1):74-79. doi: 10.1016/j.ygyno.2019.01.016. Epub 2019 Jan 18.

PMID:
30661765
17.

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study.

Crosby EJ, Gwin W, Blackwell K, Marcom PK, Chang S, Maecker HT, Broadwater G, Hyslop T, Kim S, Rogatko A, Lubkov V, Snyder JC, Osada T, Hobeika AC, Morse MA, Lyerly HK, Hartman ZC.

Clin Cancer Res. 2019 May 1;25(9):2725-2736. doi: 10.1158/1078-0432.CCR-18-3102. Epub 2019 Jan 11.

PMID:
30635338
18.

Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.

Davidson BA, Broadwater G, Crim A, Boccacio R, Bixel K, Backes F, Previs RA, Salinaro J, Salani R, Moore K, Secord AA.

Gynecol Oncol. 2019 Mar;152(3):554-559. doi: 10.1016/j.ygyno.2018.12.011. Epub 2018 Dec 14.

PMID:
30558972
19.

Findings on Surveillance Imaging After Preoperative Partial Breast Irradiation for Early Stage Breast Cancer.

Natarajan B, Spiegel D, Nichols EM, Feigenberg S, Blitzblau R, Broadwater G, Duffy EA, Baker JA, Horton JK.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1374-1381. doi: 10.1016/j.ijrobp.2018.05.059. Epub 2018 Jun 5.

20.

A Multicenter Analysis Examining Patients Undergoing Conversion of Implant-based Breast Reconstruction to Abdominally based Free Tissue Transfer.

Zhao R, Tran BNN, Doval AF, Broadwater G, Buretta KJ, Orr JP, Lee BT, Hollenbeck ST.

J Reconstr Microsurg. 2018 Nov;34(9):685-691. doi: 10.1055/s-0038-1641680. Epub 2018 May 7.

PMID:
29734445
21.

The risk of carotid stenosis in head and neck cancer patients after radiation therapy.

Carpenter DJ, Mowery YM, Broadwater G, Rodrigues A, Wisdom AJ, Dorth JA, Patel PR, Shortell CK, Clough R, Brizel DM.

Oral Oncol. 2018 May;80:9-15. doi: 10.1016/j.oraloncology.2018.02.021. Epub 2018 Mar 14.

22.

Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.

Force J, Howie LJ, Abbott SE, Bentley R, Marcom PK, Kimmick G, Westbrook K, Sammons SL, Parks M, Topping DL, Emerson R, Broadwater G, Hyslop T, Blackwell KL, Nair SK.

Clin Breast Cancer. 2018 Oct;18(5):410-417. doi: 10.1016/j.clbc.2018.02.010. Epub 2018 Feb 24.

PMID:
29615305
23.

Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?

Hong JC, Foote J, Broadwater G, Sosa JA, Gaillard S, Havrilesky LJ, Chino JP.

JCO Clin Cancer Inform. 2017 Nov;1:1-15. doi: 10.1200/CCI.16.00072.

24.

Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.

Lee PS, Kempner S, Miller M, Dominguez J, Grotegut C, Ehrisman J, Previs R, Havrilesky LJ, Broadwater G, Ellestad SC, Secord AA.

Gynecol Oncol Res Pract. 2017 Aug 22;4:11. doi: 10.1186/s40661-017-0049-6. eCollection 2017.

25.

Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition.

Osada T, Morse MA, Hobeika A, Diniz MA, Gwin WR, Hartman Z, Wei J, Guo H, Yang XY, Liu CX, Kaneko K, Broadwater G, Lyerly HK.

Oncoimmunology. 2017 Apr 12;6(6):e1315495. doi: 10.1080/2162402X.2017.1315495. eCollection 2017.

26.

Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.

Hong JC, Foote J, Broadwater G, Gaillard S, Havrilesky LJ, Chino JP.

Int J Gynecol Cancer. 2017 May;27(4):720-729. doi: 10.1097/IGC.0000000000000926.

PMID:
28375927
27.

Disparities in the surgical staging of high-grade endometrial cancer in the United States.

Foote JR, Gaillard S, Broadwater G, Sosa JA, Davidson B, Adam MA, Secord AA, Jones MB, Chino J, Havrilesky LJ.

Gynecol Oncol Res Pract. 2017 Jan 19;4:1. doi: 10.1186/s40661-016-0036-3. eCollection 2017.

28.

Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.

Sung AD, Sung JAM, Thomas S, Hyslop T, Gasparetto C, Long G, Rizzieri D, Sullivan KM, Corbet K, Broadwater G, Chao NJ, Horwitz ME.

Clin Infect Dis. 2016 Oct 15;63(8):999-1006. doi: 10.1093/cid/ciw451. Epub 2016 Aug 1.

29.

Performance of sentinel lymph node biopsy in high-risk endometrial cancer.

Ehrisman J, Secord AA, Berchuck A, Lee PS, Di Santo N, Lopez-Acevedo M, Broadwater G, Valea FA, Havrilesky LJ.

Gynecol Oncol Rep. 2016 Apr 19;17:69-71. doi: 10.1016/j.gore.2016.04.002. eCollection 2016 Aug.

30.

Tumor grade and chemotherapy response in endometrioid endometrial cancer.

Davidson BA, Foote J, Clark LH, Broadwater G, Ehrisman J, Gehrig P, Graybill W, Alvarez Secord A, Havrilesky LJ.

Gynecol Oncol Rep. 2016 Apr 27;17:3-6. doi: 10.1016/j.gore.2016.04.006. eCollection 2016 Aug.

31.

Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer.

Merk BA, Havrilesky LJ, Ehrisman JA, Broadwater G, Habib AS.

Curr Med Res Opin. 2016;32(3):453-8. doi: 10.1185/03007995.2015.1123146. Epub 2016 Jan 1.

PMID:
26583436
32.

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer.

Zhang C, Roque D, Ehrisman JA, DiSanto N, Broadwater G, Doll KM, Gehrig PA, Secord AA, Havrilesky LJ.

Gynecol Oncol Rep. 2015 Jun 18;13:49-52. doi: 10.1016/j.gore.2015.06.004. eCollection 2015 Aug.

33.

Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers.

Horton JK, Blitzblau RC, Yoo S, Geradts J, Chang Z, Baker JA, Georgiade GS, Chen W, Siamakpour-Reihani S, Wang C, Broadwater G, Groth J, Palta M, Dewhirst M, Barry WT, Duffy EA, Chi JT, Hwang ES.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):846-55. doi: 10.1016/j.ijrobp.2015.03.007. Epub 2015 Mar 14.

34.

Postoperative Pain Scores and Narcotic Use in Robotic-assisted Versus Laparoscopic Hysterectomy for Endometrial Cancer Staging.

Turner TB, Habib AS, Broadwater G, Valea FA, Fleming ND, Ehrisman JA, Di Santo N, Havrilesky LJ.

J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):1004-10. doi: 10.1016/j.jmig.2015.05.003. Epub 2015 May 9.

PMID:
25967934
35.

Exercise behavior and patient-reported outcomes in women with early breast cancer receiving locoregional radiation therapy.

Arya R, Siamakpour-Reihani S, Palta M, Massa L, Broadwater G, Blitzblau RC, Horton JK.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):e275-81. doi: 10.1016/j.prro.2015.01.003. Epub 2015 Feb 26.

PMID:
25731964
36.

Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study.

Glass OK, Inman BA, Broadwater G, Courneya KS, Mackey JR, Goruk S, Nelson ER, Jasper J, Field CJ, Bain JR, Muehlbauer M, Stevens RD, Hirschey MD, Jones LW.

Br J Cancer. 2015 Mar 3;112(5):825-31. doi: 10.1038/bjc.2014.662. Epub 2015 Jan 13.

37.

Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial.

Teoh D, Lowery WJ, Jiang X, Ehrisman J, Halvorson P, Broadwater G, Bentley R, Secord AA, Sobolewski C, Berchuck A, Havrilesky LJ, Valea FA, Lee PS.

J Minim Invasive Gynecol. 2015 Feb;22(2):227-33. doi: 10.1016/j.jmig.2014.10.002. Epub 2014 Oct 8.

PMID:
25305572
38.

Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer.

Previs RA, Kilgore J, Craven R, Broadwater G, Bean S, Wobker S, DiFurio M, Bae-Jump V, Gehrig PA, Secord AA.

Int J Gynecol Cancer. 2014 May;24(4):670-5. doi: 10.1097/IGC.0000000000000109.

39.

Optimizing the quality of breast cancer biomarker use at Duke Cancer Institute.

Kamal AH, Power S, Broadwater G, Holland AR, Marcom PK.

J Natl Compr Canc Netw. 2014 Feb;12 Suppl 1:S21-4.

40.

Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.

Zhang C, Havrilesky LJ, Broadwater G, Di Santo N, Ehrisman JA, Lee PS, Berchuck A, Alvarez Secord A, Bean S, Bentley RC, Valea FA.

Gynecol Oncol. 2014 May;133(2):211-5. doi: 10.1016/j.ygyno.2014.02.025. Epub 2014 Feb 28.

PMID:
24582867
41.

Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control.

Patel PR, Kirkpatrick J, Salama JK, Nelson J, Broadwater G, Allen K, Clough R, Yin FF, Wang Z, Chang Z, Kelsey C, Ghafoori AP.

J Radiosurg SBRT. 2014;3(2):123-129.

42.

TP53 Status is Associated with Thrombospondin1 Expression In vitro.

Alvarez Secord A, Bernardini MQ, Broadwater G, Grace LA, Huang Z, Baba T, Kondoh E, Sfakianos G, Havrilesky LJ, Murphy SK.

Front Oncol. 2013 Oct 29;3:269. doi: 10.3389/fonc.2013.00269. eCollection 2013.

43.

Nab-paclitaxel/bevacizumab/carboplatin chemotherapy in first-line triple negative metastatic breast cancer.

Hamilton E, Kimmick G, Hopkins J, Marcom PK, Rocha G, Welch R, Broadwater G, Blackwell K.

Clin Breast Cancer. 2013 Dec;13(6):416-20. doi: 10.1016/j.clbc.2013.08.003. Epub 2013 Oct 4.

PMID:
24099649
44.

Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.

Jones LW, Fels DR, West M, Allen JD, Broadwater G, Barry WT, Wilke LG, Masko E, Douglas PS, Dash RC, Povsic TJ, Peppercorn J, Marcom PK, Blackwell KL, Kimmick G, Turkington TG, Dewhirst MW.

Cancer Prev Res (Phila). 2013 Sep;6(9):925-37. doi: 10.1158/1940-6207.CAPR-12-0416. Epub 2013 Jul 10.

45.

Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers.

Jewell EL, Smrtka M, Broadwater G, Valea F, Davis DM, Nolte KC, Valea R, Myers ER, Havrilesky LJ.

Int J Gynecol Cancer. 2013 Jul;23(6):1158-66. doi: 10.1097/IGC.0b013e318299e2a6.

PMID:
23792609
46.

Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.

Lopez-Acevedo M, Havrilesky LJ, Broadwater G, Kamal AH, Abernethy AP, Berchuck A, Alvarez Secord A, Tulsky JA, Valea F, Lee PS.

Gynecol Oncol. 2013 Jul;130(1):156-61. doi: 10.1016/j.ygyno.2013.04.010. Epub 2013 Apr 13.

PMID:
23587882
47.

Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy.

Dorth JA, Patel PR, Broadwater G, Brizel DM.

Head Neck. 2014 Feb;36(2):215-9. doi: 10.1002/hed.23280. Epub 2013 Apr 2.

48.

The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer.

Bolac CS, Wallace AH, Broadwater G, Havrilesky LJ, Habib AS.

Anesth Analg. 2013 May;116(5):1041-7. doi: 10.1213/ANE.0b013e318276cf58. Epub 2013 Jan 21.

PMID:
23337415
49.

A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer.

Secord AA, Geller MA, Broadwater G, Holloway R, Shuler K, Dao NY, Gehrig PA, O'Malley DM, Finkler N, Havrilesky LJ.

Gynecol Oncol. 2013 Jan;128(1):65-70. doi: 10.1016/j.ygyno.2012.10.010. Epub 2012 Oct 17.

PMID:
23085460
50.

A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer.

Secord AA, Teoh DK, Barry WT, Yu M, Broadwater G, Havrilesky LJ, Lee PS, Berchuck A, Lancaster J, Wenham RM.

Clin Cancer Res. 2012 Oct 1;18(19):5489-98. doi: 10.1158/1078-0432.CCR-12-0507. Epub 2012 Jul 26.

Supplemental Content

Loading ...
Support Center